Trial Profile
Efficacy of Ferric Carboxymaltose (Ferinject) in Anemic Patients Anticipating Pancreatoduodenectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 27 Apr 2020 Status changed from recruiting to completed.
- 27 Mar 2017 Planned End Date changed from 1 Dec 2016 to 30 Jun 2018.
- 27 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 30 Jun 2018.